Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,797
Award facts
- Contract value 100% obligated
- $11,796.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,796.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, requires no set-aside designation and represents one of numerous pharmaceutical supply orders issued to the contractor. The delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group's PPV-G GEN V contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning the company as a critical regional prime vendor within the Department of Defense's global pharmaceutical supply chain. Under this contract structure, DLA authorizes firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support military healthcare facilities worldwide. The PPV-G GEN V program itself represents a $30.3 billion acquisition strategy managed by the Defense Logistics Agency to modernize pharmaceutical supply operations across the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMPV?
SPE2DU26FEMPV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DU26FEMPV worth?
The government has obligated $11,797 on SPE2DU26FEMPV.
Is contract SPE2DU26FEMPV an order under another contract?
Yes. SPE2DU26FEMPV is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPV competed?
The extent of competition for SPE2DU26FEMPV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award